vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and XBP Global Holdings, Inc. (XBP). Click either name above to swap in a different company.
XBP Global Holdings, Inc. is the larger business by last-quarter revenue ($152.4M vs $90.3M, roughly 1.7× Evolus, Inc.). Evolus, Inc. runs the higher net margin — 0.1% vs -200.7%, a 200.8% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs -34.7%). Evolus, Inc. produced more free cash flow last quarter ($11.3M vs $10.5M).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
EOLS vs XBP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.3M | $152.4M |
| Net Profit | $130.0K | $-305.8M |
| Gross Margin | 65.7% | 21.7% |
| Operating Margin | 4.7% | -191.7% |
| Net Margin | 0.1% | -200.7% |
| Revenue YoY | 14.4% | -34.7% |
| Net Profit YoY | 101.9% | -980.1% |
| EPS (diluted) | $0.01 | $-2.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.3M | — | ||
| Q3 25 | $69.0M | $152.4M | ||
| Q2 25 | $69.4M | — | ||
| Q1 25 | $68.5M | — | ||
| Q4 24 | $78.9M | — | ||
| Q3 24 | $61.1M | $233.4M | ||
| Q2 24 | $66.9M | — | ||
| Q1 24 | $59.3M | — |
| Q4 25 | $130.0K | — | ||
| Q3 25 | $-15.7M | $-305.8M | ||
| Q2 25 | $-17.1M | — | ||
| Q1 25 | $-18.9M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-19.2M | $-28.3M | ||
| Q2 24 | $-11.3M | — | ||
| Q1 24 | $-13.1M | — |
| Q4 25 | 65.7% | — | ||
| Q3 25 | 66.5% | 21.7% | ||
| Q2 25 | 65.3% | — | ||
| Q1 25 | 68.1% | — | ||
| Q4 24 | 66.7% | — | ||
| Q3 24 | 68.9% | 18.9% | ||
| Q2 24 | 70.3% | — | ||
| Q1 24 | 68.3% | — |
| Q4 25 | 4.7% | — | ||
| Q3 25 | -16.7% | -191.7% | ||
| Q2 25 | -14.7% | — | ||
| Q1 25 | -22.1% | — | ||
| Q4 24 | -2.9% | — | ||
| Q3 24 | -25.3% | 0.9% | ||
| Q2 24 | -11.5% | — | ||
| Q1 24 | -15.0% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -22.8% | -200.7% | ||
| Q2 25 | -24.7% | — | ||
| Q1 25 | -27.6% | — | ||
| Q4 24 | -8.6% | — | ||
| Q3 24 | -31.4% | -12.1% | ||
| Q2 24 | -17.0% | — | ||
| Q1 24 | -22.1% | — |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $-0.24 | $-2.60 | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.30 | — | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.30 | $-0.09 | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.8M | $34.5M |
| Total DebtLower is stronger | $146.1M | $381.5M |
| Stockholders' EquityBook value | $-23.1M | $130.5M |
| Total Assets | $225.9M | $947.9M |
| Debt / EquityLower = less leverage | — | 2.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.8M | — | ||
| Q3 25 | $43.5M | $34.5M | ||
| Q2 25 | $61.7M | — | ||
| Q1 25 | $67.9M | — | ||
| Q4 24 | $87.0M | — | ||
| Q3 24 | $85.0M | $7.8M | ||
| Q2 24 | $93.7M | — | ||
| Q1 24 | $97.0M | — |
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | $381.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | $31.5M | ||
| Q2 24 | $120.9M | — | ||
| Q1 24 | $120.6M | — |
| Q4 25 | $-23.1M | — | ||
| Q3 25 | $-28.8M | $130.5M | ||
| Q2 25 | $-18.7M | — | ||
| Q1 25 | $-6.6M | — | ||
| Q4 24 | $5.5M | — | ||
| Q3 24 | $5.9M | $-1.3B | ||
| Q2 24 | $19.3M | — | ||
| Q1 24 | $18.4M | — |
| Q4 25 | $225.9M | — | ||
| Q3 25 | $219.0M | $947.9M | ||
| Q2 25 | $228.8M | — | ||
| Q1 25 | $213.4M | — | ||
| Q4 24 | $232.6M | — | ||
| Q3 24 | $229.6M | $99.6M | ||
| Q2 24 | $233.8M | — | ||
| Q1 24 | $226.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.92× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — | ||
| Q1 24 | 6.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.8M | $13.9M |
| Free Cash FlowOCF − Capex | $11.3M | $10.5M |
| FCF MarginFCF / Revenue | 12.6% | 6.9% |
| Capex IntensityCapex / Revenue | 1.6% | 2.2% |
| Cash ConversionOCF / Net Profit | 98.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.8M | — | ||
| Q3 25 | $-14.7M | $13.9M | ||
| Q2 25 | $-24.8M | — | ||
| Q1 25 | $-15.6M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $-5.7M | $-1.5M | ||
| Q2 24 | $-6.5M | — | ||
| Q1 24 | $-10.6M | — |
| Q4 25 | $11.3M | — | ||
| Q3 25 | $-15.6M | $10.5M | ||
| Q2 25 | $-25.5M | — | ||
| Q1 25 | $-16.0M | — | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $-6.0M | $-6.1M | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-10.9M | — |
| Q4 25 | 12.6% | — | ||
| Q3 25 | -22.7% | 6.9% | ||
| Q2 25 | -36.7% | — | ||
| Q1 25 | -23.3% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | -9.9% | -2.6% | ||
| Q2 24 | -10.4% | — | ||
| Q1 24 | -18.3% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.4% | 2.2% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.5% | 2.0% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 98.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
Segment breakdown not available.
XBP
| Related And Non Related Party | $136.5M | 90% |
| Technology | $8.2M | 5% |
| Other | $5.7M | 4% |
| Deferred Revenue As Of July312025 | $1.9M | 1% |
